drugset / Trial / NCT03632824

Tranexamic Acid in Pregnancies With Vaginal Bleeding

NCT03632824 ↗

Completed 139 enrolled Hawler Medical University
Non-randomizedSequentialOpen-labelTreatment

Summary

Tranexamic acid has been proposed and used for prevention and management of antepartum and postpartum hemorrhage.

Timeline

Start
2016-02-01
Primary completion
2020-01-15
Completion
2020-01-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 500 mg Intravenous

Indications